Shield Therapeutics (AgeTech UK) Biomed
Small molecule discovery, iron deficiencies. Dementia-related. Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership